Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 78.57M
50.8x5.78x-0.73x4.75x19.31x26.83x2.94% 281B
22.45x1.89x-16.81x3.1x11.03x18.09x1.75% 66.27B
16.49x1.42x0.82x2.08x7.14x8.53x2.71% 8.24B
10.18x10.77x0.06x5.26x8.1x8.9x - 8.13B
21.9x6.1x1.32x6.55x17.91x18.7x-.--% 4.45B
42.25x2.52x-1.38x2.39x29.15x43.18x0.73% 3.71B
29.4x - 0.19x5.61x16.05x26.01x - 3.42B
102.42x - -0.63x - - - -.--% 2.58B
12.61x0.84x0.89x1.13x28.49x-77.63x4.06% 1.01B
-7.43x12.42x0.46x205.42x-6.61x-5.18x-.--% 961M
44.17x6.92x-1.15x14.72x30.91x36.36x - 928M
44.9x - -0.09x - - - - 890M
Average 32.51x 5.41x -1.42x 25.10x 16.15x 10.38x 1.52% 29.38B
Weighted average by Cap. 43.73x 5.08x -3.44x 4.95x 17.39x 24.24x 2.64%
Specialty & Advanced Pharmaceuticals
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!